Hepatitis doesn’t always announce itself. While hepatitis A often comes on abruptly, as with a bad stomach bug, most cases of ...
BMS's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory ...
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in ...
CAR-T was developed to wipe out hard-to-treat blood cancers. But the cells that go bad in leukemias and lymphomas — immune ...
Research reveals that silica scaffolds can train the immune system against S. aureus, offering a novel approach to prevent ...
A new nanoparticle vaccine successfully prevented several aggressive cancers in mice, including pancreatic and melanoma. The ...
A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
Background Chronic hepatitis B virus (HBV) infection disproportionately affects people living with HIV, who are often excluded from functional cure studies. Objective This study investigates CD8+ T ...
Cancer is a multifactorial chronic disease, with its pathogenesis and progression influenced by various factors. The immune ...
Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...
Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...
While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback